StemCell Therapy

(MENAFN - ForPressRelease) 11

New Delhi 23rd January 2020 On Saturday, January 18th, 2020, the Advancells Group & the International Fertility Center together ended their first workshop Sub-Specialty Training in Application of Regenerative Medicine (S.T.A.R. 2020). The three-day workshop had specialized doctors, medical practitioners, learned scientists of Advancells, the leaders in cell manufacturing & processes and IFC, one of India's most prestigious Fertility institute who were joined by candidates with MBBS/BAMS/BHMS/BPharma & Master's degree in Life Sciences.

The key-note speaker of the workshop was Dr. Rita Bakshi, founder and chairperson of International Fertility Centre, the oldest fertility clinic and one of the most renowned IVF clinics in India, one of the organizers of the event. Participants also had a privilege to listen to Dr. Sachin Kadam, CTO, Advancells and gain hands-on experience in the preparation of PRP; Liposuction method; and Bone Marrow aspiration. All these techniques were talked about at length and demonstrated in the form of manual & kit-based models to help the candidates gain exposure.

Dr. Punit Prabha, Head of Clinical Research and Dr. Shradha Singh Gautam, Head of Lab Operations at Advancells successfully set the base of stem cell biology for the participants who were experts in gynecology field, stem cell research and pain specialist. With the help of detailed analysis of 'Application of PRP for Skin rejuvenation'; 'Preparation of Micro-fragmented Adipose Tissue and Nano Fat & SVF (Stromal Vascular Fraction) from Adipose Tissue'; and 'Cell Culturing and Expansion in a Laboratory', applicants understood the application of stem cells in aesthetics, cosmetology, and anti-aging.

Vipul Jain, Founder & CEO of Advancells Group said, 'Educating young scientists about stem cells is important for us. With this workshop we wanted to discuss and share the challenges and lessons we have learned in our journey of curing our customers. We wanted to establish more concrete knowledge base in the presence of subject matter experts and help our attendees in more possible ways. We are hopeful to have successfully achieved what we claimed with this workshop'.

Given the resounding success of the Sub-Specialty Training in Application of Regenerative Medicine (S.T.A.R. 2020), it's hoped that the future events shall offer even greater wisdom to the participants by helping them improve and the lead the community into the age of greater awareness.

Advancells Group Advancells is leading the field of stem cell therapies in India and abroad, with representative offices in Bangladesh and Australia. The company provides arrangements for stem cell banking and protocols for partner doctors and hospitals which they can use for treating the patients using regenerative medicine. With a GMP compliant research and processing center that works on different cell lines from various sources such as Bone Marrow, Adipose Tissue, Dental Pulp, Blood, Cord Tissue etc. Advancells also intends to file a patent for this processing technology soon.

User :- Ajit Singh

Email :

Mobile:- 9953809503

MENAFN2401202000703206ID1099596615

More:
Advancells Group & IFC Concluded their 3-Day Workshop on Regenerative Medicine - MENAFN.COM

The Ceramic Tableware Market analysis report is very indispensable in many ways for business growth and to thrive in the market. Getting well-versed about the trends and opportunities in the industry is fairly time consuming process.

Along with explaining competitive landscape of the key players, this Ceramic Tableware Market promotional report also provides complete and distinct analysis of the market drivers and restraints, detailed analysis of the market segmentation, key developments in the market and details of research methodology.

Global Ceramic Tableware Market is expected to rise from its initial estimated value of USD 62.03 billion in 2018 to an estimated value of USD 91.44 billion by 2026, registering a CAGR of 4.97% in the forecast period of 2019-2026

Click Here to Get Sample Report Of Ceramic Tableware Market

The Major players profiled in this report include Fiskars villeroy & boch, Rosenthal GmbH, Weiye Ceramics Co., Ltd., Guangxi Sanhuan Enterprise Group Holding Co., Ltd., GUANGDONG SITONG GROUP CO.,LTD, Hunan Hualian China Industry Co., Ltd., Guangdong Songfa Ceramics Co., Ltd., TATA Ceramics Limited, WEIYE CERAMICS CO., LTD, GUANGDONG SITONG GROUP CO.,LTD, Churchill China (UK) Ltd., Homer Laughlin China Company, Rosenthal, staatliche porzellan-manufaktur meissen gmbh, KAHLA/Thringen Porzellan GmbH.

There are 13 Chapters to thoroughly display the Ceramic Tableware market.

1 Report Overview

2 Global Growth Trends

3 Market Share by Key Players

4 Breakdown Data by Type and Application

5 Ceramic Tableware market Size by Regions

6 Sales Channel, Distributors, Traders and Dealers

7 North America Ceramic Tableware Revenue by Countries

8 Europe Ceramic Tableware Revenue by Countries

9 Asia-Pacific Ceramic Tableware Revenue by Countries

10 South America Ceramic Tableware Revenue by Countries

11 Middle East and Africa Revenue Ceramic Tableware by Countries

12 International Players Profiles

13 Market Forecast 2019-2026

14 Analysts Viewpoints/Conclusions

15 Appendix

Read Complete Details with TOC, CLICK HERE

Competitive Rivalry-: The Ceramic Tableware report incorporates the detailed analysis of the leading organizations and their thought process and what are the methodologies they are adopting to maintain their brand image in this market. The report aides the new bees to understand the level of competition that they need to fight for to strengthen their roots in this competitive market.

Conducts Overall CERAMIC TABLEWARE Market Segmentation: This knowledgeable market research report offers lucrative opportunities by breaking down complex market data into segments on the basis of

The CERAMIC TABLEWARE report covers market shares for global, Europe, North America, Asia Pacific and South America. The analysis of this report has been used to examine various segments that are relied upon to witness the quickest development based on the estimated forecast frame.

Highlights following MARKET DRIVERS AND RESTRAINT:

One of the important factors in Ceramic Tableware Market report is the competitive analysis. The report covers all the key parameters such as product innovation, market strategies of the key players, market share, revenue generation, latest research and development, and market expert views.

For any special requirements in this report, please contact us to order a report tailored to fit your requirements.

About Us:

Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Read the original post:
Dental File and Burs Market Size by Global Industry Share, Growth, Regional Analysis, Upcoming Trends, Key Manufacturers, Technology Updates and...

Press release

Gosselies, Belgium, 9 January 2020, 7 am CET BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address highly unmet medical needs in orthopaedics and bone diseases, today announces that Chief Executive Officer, Dr. Miguel Forte, MD, PhD, will attend the 38th Annual J.P. Morgan Healthcare Conference in San Francisco, 13-16 January 2020.

If you would like to meet with Dr. Miguel Forte from Bone Therapeutics at the conference, please contact investorrelations@bonetherapeutics.com.

The Company will also host, in collaboration with Arrowhead Business and Investment Decisions, LLC investor meetings in New York and Boston on 23 and 24 January.

About Bone Therapeutics

Bone Therapeutics is a leading biotech company focused on the development of innovative products to address high unmet needs in orthopaedics and bone diseases. Based in Gosselies, Belgium, the Company has a broad, diversified portfolio of bone cell therapy and an innovative biological product in later-stage clinical development across a number of disease areas, which target markets with large unmet medical needs and limited innovation.

Bone Therapeutics is developing an off-the-shelf protein solution, JTA-004, which is expected to enter Phase III development for the treatment of pain in knee osteoarthritis following the positive Phase IIb efficacy results in patients with knee osteoarthritis which showed a statistically significant improvement in pain relief compared to a leading viscosupplement. The clinical trial application (CTA) to start the pivotal Phase III program has been submitted to the regulatory authorities in Europe and the trial is expected to start in Q1 2020.

Bone Therapeutics other core technology is based on its cutting-edge allogeneic cell therapy platform (ALLOB) which can be stored at the point of use in the hospital, and uses a unique, proprietary approach to bone regeneration, which turns undifferentiated stem cells from healthy donors into bone-forming cells. These cells can be administered via a minimally invasive procedure, avoiding the need for invasive surgery, and are produced via a proprietary, scalable cutting-edge manufacturing process. Following the strong Phase IIa efficacy and safety results for ALLOB, the Company plans to submit a CTA with the regulatory authorities before year-end 2019 to initiate a Phase IIb clinical trial with ALLOB in patients with difficult-to-heal fractures, using its optimized production process.

The ALLOB platform technology has multiple applications and will continue to be evaluated in other indications including spinal fusion, osteotomy and maxillofacial and dental applications.

Bone Therapeutics cell therapy products are manufactured to the highest GMP (Good Manufacturing Practices) standards and are protected by a broad IP (Intellectual Property) portfolio covering ten patent families as well as knowhow. Further information is available at http://www.bonetherapeutics.com.

Contacts

Bone Therapeutics SAMiguel Forte, MD, PhD, Chief Executive OfficerJean-Luc Vandebroek, Chief Financial OfficerTel: +32 (0) 71 12 10 00investorrelations@bonetherapeutics.com

International Media Enquiries:Consilium Strategic CommunicationsMarieke VermeerschTel: +44 (0) 20 3709 5701bonetherapeutics@consilium-comms.com

For French Media and Investor Enquiries:NewCap Investor Relations & Financial CommunicationsPierre Laurent, Louis-Victor Delouvrier and Arthur RouillTel: + 33 (0)1 44 71 94 94bone@newcap.eu

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors` current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person`s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Story continues

View post:
Bone Therapeutics announces attendance at the 38th Annual J.P. Morgan Healthcare Conference - Yahoo Finance

Regulated information

Gosselies, Belgium, 30December 2019, 7am CET BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the leading biotech company focused on the development of innovative cell and biological therapies to address high unmet medical needs in orthopaedics and bone diseases, today announces an increase in the total number of voting rights and shares as a result of the issuance of new shares on 18December 2019 following the conversion of convertible bonds issued on the private placement on 7March 2018. The following information is published in accordance with Article15 of the Belgian Law of 2May 2007 on the publication of major shareholdings in issuers whose shares are admitted to trading on regulated market.

(1) On 12 December 2019, the Extraordinary General Shareholders Meeting approved the reduction of the issue premiums and the paid-up capital of the Company by absorption of losses carried forward without cancellation of titles. As a result, the share capital was reduced for a total amount of EUR 10,592,226 and the par value of Companys share decreased from EUR 1.51 to EUR 0.51.

(2) The total number of attributed warrants have been reduced due to 130,500 warrants becoming void.

(3) Based on the conversion price of EUR3.2576 (92% of the Volume-Weighted-Averaged-Price of Bone Therapeutics on 18December 2019).

About Bone Therapeutics

Bone Therapeutics is a leading biotech company focused on the development of innovative products to address high unmet needs in orthopaedics and bone diseases. Based in Gosselies, Belgium, the Company has a broad, diversified portfolio of bone cell therapy and an innovative biological product in later-stage clinical development across a number of disease areas, which target markets with large unmet medical needs and limited innovation.

Bone Therapeutics is developing an off-the-shelf protein solution, JTA-004, which is expected to enter Phase III development for the treatment of pain in knee osteoarthritis further to reported positive Phase IIb efficacy results in patients with knee osteoarthritis, showing a statistically significant improvement in pain relief compared to a leading viscosupplement. The Phase III program with JTA-004 in patients with knee osteoarthritis shall start in Q1 2020 and the Company is currently submitting the related clinical trial application (CTA) with the regulatory authorities in Europe.

Bone Therapeutics other core technology is based on its cutting-edge allogeneic cell therapy platform (ALLOB) which can be stored at the point of use in the hospital, and uses a unique, proprietary approach to bone regeneration, which turns undifferentiated stem cells from healthy donors into bone-forming cells. These cells can be administered via a minimally invasive procedure, avoiding the need for invasive surgery, and are produced via a proprietary, cutting-edge manufacturing process. Further to recently reported strong Phase IIa efficacy and safety results for ALLOB, the Company plans to submit a CTA with the regulatory authorities before year-end to initiate a Phase IIb clinical trial with ALLOB in patients with difficult-to-heal fractures, using its optimized production process.

The Companys lead product candidate in the ALLOB product pipeline is a regenerative cell therapy that is expected to enter Phase IIb clinical development for the treatment of difficult-to-heal fractures. The ALLOB platform technology has many other applications and will continue to be evaluated in other applications like spinal fusion, maxilofacial, dental and osteotomy.

Bone Therapeutics cell therapy products are manufactured to the highest GMP (Good Manufacturing Practices) standards and are protected by a broad IP (Intellectual Property) portfolio covering ten patent families as well as knowhow. Further information is available at http://www.bonetherapeutics.com.

Contacts

Bone Therapeutics SAJean-Luc Vandebroek, Chief Financial OfficerTel: +32 (0) 71 12 10 00investorrelations@bonetherapeutics.com

International Media Enquiries:Consilium Strategic CommunicationsMarieke VermeerschTel: +44 (0) 20 3709 5701bonetherapeutics@consilium-comms.com

For French Media and Investor Enquiries:NewCap Investor Relations & Financial CommunicationsPierre Laurent, Louis-Victor Delouvrier and Arthur RouillTel: + 33 (0)1 44 71 94 94bone@newcap.eu

Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company or, as appropriate, the Company directors` current expectations and projections about future events. By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties and assumptions could adversely affect the outcome and financial effects of the plans and events described herein. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future. As a result, the Company expressly disclaims any obligation or undertaking to release any update or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person`s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Continued here:
Bone Therapeutics SA: Information on the total number of voting rights and shares - GlobeNewswire

From zeroing in on different cancer cures to restoring vision and hearing to the blind and deaf2019 was a year filled with medical breakthroughs.

While some of these accomplishments may be varied in their stages of research, each notable study is just one more milestone towards treating some of humanitys most debilitating conditions.

So without any further ado, lets give it up for the top ten health and medical breakthroughs of 2019.

An exciting study that was published back in January found that exposure to blue light is an effective, non-pharmaceutical treatment for high blood pressure, which simultaneously reduces the risk of developing cardiovascular disease.

The researchers who conducted the study from the University of Surrey and Heinrich Heine University Duesseldorf discovered that exposure to whole-body blue light significantly reduced the systolic blood pressure of participants by almost 8 mmHg, compared to the control light which had no impact.

Whats even more remarkable is that the reduction of blood pressure from blue light is similar to what is seen in clinical trials with blood pressure lowering drugs.

Rather than targeting the typical rogue proteins associated with dementia, scientists found earlier this month thatfor the very first timethey have reversed dementia in mice with a drug that reduces inflammation.

Up until now, most dementia treatments have targeted the amyloid plaques that are found in people with Alzheimers disease. However, experiments conducted at the University of California, Berkeley suggest targeting inflammation in the brain might stop it in its tracks.

If you didnt already have enough reason to eat your vegetables, this study published back in May says that broccoli contains an amazing ingredient which could be the Achilles heel of cancer.

Broccoli is part of the cruciferous vegetable family, which includes cauliflower, cabbage, kale and Brussels sproutsand though many people dont like their taste, these vegetables contain a tiny, but powerful molecule that deactivates the gene responsible for cancerous tumor growth, known as WWP1.

Millions of blind people could have their vision restored using stem cells taken from the eyes of non-living donors, according to Scottish research publish back in March.

Thanks to the pioneering tissue transplant, eight patients with a common condition that destroys vision had the affected area repairedand two patients were even able to read again after having severe macular degeneration.

Back in April, Canadian researchers developed a new treatment for mobility-impaired Parkinsons disease patientsand the results were beyond their wildest dreams.

Scientists from Western University in Ontario published the results of a pilot study in which they used spinal implants to improve motor function in several patients with advanced Parkinsons.

Prior to the study, the patients were barely able to stand on their own without falling over or they were forced to depend entirely on wheelchairs for mobility. After getting the spinal implant, however, the patients are now capable of walking unassisted for the first time in years.

According to a report from May, people who experience anxiety symptoms might be helped by taking steps to regulate the microorganisms in their gut using probiotic and non-probiotic food and supplements.

Anxiety symptoms are common in people with mental diseases and a variety of physical disorders, especially in disorders that are related to stress. Previous studies have shown that as many as a third of people will be affected by anxiety symptoms during their lifetime.

Increasingly, research has indicated that gut microbiotathe trillions of microorganisms in the gut which perform important functions in the immune system and metabolism by providing essential inflammatory mediators, nutrients and vitaminscan help regulate brain function through something called the gut-brain axis.

In August, researchers at Johns Hopkins Medicine may have found the key to restoring hearing in people with irreversible deafness.

Using genetic tools in mice, researchers at Johns Hopkins Medicine say they identified a pair of proteins that precisely control when sound-detecting cells, known as hair cells, are born in the mammalian inner ear.

Scientists in our field have long been looking for the molecular signals that trigger the formation of the hair cells that sense and transmit sound, says Dr. Angelika Doetzlhofer, associate professor of neuroscience at the Johns Hopkins University School of Medicine. These hair cells are a major player in hearing loss, and knowing more about how they develop will help us figure out ways to replace hair cells that are damaged.

As MDMA is now being recognized as a groundbreaking cure for emotional trauma, a new clinic in Pennsylvania could become one of the first legally-sanctioned facilities for using the psychoactive drug on treatment-resistant PTSD in the United States.

Now that it has reportedly opened its doors in Wyndmoore, The Landing medical facility will specialize in using several psychoactive drugs to treat a variety of mental health disorders.

Particularly, it has been pushing to receive FDA approval on using MDMA-assisted psychotherapy for patients whose Post-Traumatic Stress Disorder has been untreatable.

Dental fillings may soon be a thing of the past, thanks to this breakthrough from Chinese scientists.

Enamel is the mineralized substance that protects the surface of teeth. Though it is one of the toughest tissues in our bodies, it is prone to degradation over time particularly as a result of consistent exposure to certain acids that are found in food and drinks.

We currently use resins and ceramics to fill in deteriorated enamel, but these fillings can often become loose within just a few years of their placementand with tooth decay being one of the most prevalent chronic diseases amongst humans, scientists have puzzled over how they can recreate enamel.

Until now, we have not been able to reproduce the toughened tissue because of its complex cellular structurebut back in September, a team of researchers from Zhejiang University School of Medicine developed a gel that makes enamel repair itself.

With pancreatic cancer ranking as one of the most deadly forms of cancer, researchers were excited to report on a promising new breakthrough for a treatment.

Pancreatic cancer, which maintains a 95% mortality rate, is resistant to all current treatments. Patients have extremely poor chances of surviving for five years after being diagnosedand since the disease does not show symptoms until the advanced stages, it is notoriously hard to diagnose.

However, this Tel Aviv University study published earlier this month finds that a small molecule has the ability to induce the self-destruction of pancreatic cancer cells. The research was conducted with xenograftstransplantations of human pancreatic cancer into immunocompromised mice. The treatment reduced the number of cancer cells by 90% in the developed tumors a month after being administered.

Cure Your Friends Of Negativity By Sharing The Good News To Social Media

Follow this link:
Healing Dose of Optimism: The Top 10 Medical Breakthroughs of 2019 Will Have You Cheering - Good News Network

Medical technology now tells us that when kids'baby teeth are kept safe,valuable cells are stored inside that can lead to possibly life-changing research work with stem cells down the road.

Remember when you were a kid and you couldn't wait until that pesky loose tooth finally wiggled itself free so that you could put it under your pillow and wait for a visit from the mysterious Tooth Fairy? A gift in exchange for an old tooth seemed like a pretty sweet deal at age 7 but now, according to medical professionals, those fallen baby teeth are the true gift; worth their weight in stem cell gold.

RELATED: 10 UNPLEASANT TRUTHS ABOUT BABY TEETHING (AND 10 THINGS MOM CAN ACTUALLY DO)

According to Small Joys, baby teeth are made nearly entirely of cells and these dental cells are going to be in big demand in the future. The reason for this is that our bodies are made completely of cells, divided in three categories of functionalities. Dental cells belong into the stem cell category and because these are caught at the early stage of development in your child's life, they just might be able to save your child's life down the road should the occasion ever arise.

For such an amazing task, you might be thinking how much is the storage going to cost at the expensive cryogenic laboratory that you're going to have to find to keep your child's baby teeth at? But no worries there because Small Joys says that according to medical technology professionals, the dental cells are already perfect preserved in their own little chambers. All you need to do is provide them with a nice, dry, safe and clean environment. This can be something as simple as a little BPA-free box with a snap lid.

NEXT:METALS IN BABY TEETH MAY HELP REVEAL THE CAUSES OF AUTISM, ADHD, STUDY SAYS

Be sure to mark the outside with the contents such as your child's complete name, the date they lost their tooth, the age they lost the tooth at, and maybe even the location of the tooth if you can. You can easily find a dental chart online. If you're feeling fancy, there are even some little cases made just for the occasion that comes with spaces for each tooth! Can't go wrong there.

In the end, hanging on to baby teeth is important to help doctors and scientists help make great strides in the world of stem cell research and breakthroughs with major diseases. Plus you've got to admit that it's also kind of cute to save for the memories, too!

Kenya Moore Of "RHOA" Shares Video Of 13-Month-Old Daughter Taking Her First Steps

Tags:health

Link:
Keeping Your Childs Baby Teeth Could Save Their Life In The Future - BabyGaga

Updated: May 25, 2018:

JD Supra is a legal publishing service that connects experts and their content with broader audiences of professionals, journalists and associations.

This Privacy Policy describes how JD Supra, LLC ("JD Supra" or "we," "us," or "our") collects, uses and shares personal data collected from visitors to our website (located at http://www.jdsupra.com) (our "Website") who view only publicly-available content as well as subscribers to our services (such as our email digests or author tools)(our "Services"). By using our Website and registering for one of our Services, you are agreeing to the terms of this Privacy Policy.

Please note that if you subscribe to one of our Services, you can make choices about how we collect, use and share your information through our Privacy Center under the "My Account" dashboard (available if you are logged into your JD Supra account).

Registration Information. When you register with JD Supra for our Website and Services, either as an author or as a subscriber, you will be asked to provide identifying information to create your JD Supra account ("Registration Data"), such as your:

Other Information: We also collect other information you may voluntarily provide. This may include content you provide for publication. We may also receive your communications with others through our Website and Services (such as contacting an author through our Website) or communications directly with us (such as through email, feedback or other forms or social media). If you are a subscribed user, we will also collect your user preferences, such as the types of articles you would like to read.

Information from third parties (such as, from your employer or LinkedIn): We may also receive information about you from third party sources. For example, your employer may provide your information to us, such as in connection with an article submitted by your employer for publication. If you choose to use LinkedIn to subscribe to our Website and Services, we also collect information related to your LinkedIn account and profile.

Your interactions with our Website and Services: As is true of most websites, we gather certain information automatically. This information includes IP addresses, browser type, Internet service provider (ISP), referring/exit pages, operating system, date/time stamp and clickstream data. We use this information to analyze trends, to administer the Website and our Services, to improve the content and performance of our Website and Services, and to track users' movements around the site. We may also link this automatically-collected data to personal information, for example, to inform authors about who has read their articles. Some of this data is collected through information sent by your web browser. We also use cookies and other tracking technologies to collect this information. To learn more about cookies and other tracking technologies that JD Supra may use on our Website and Services please see our "Cookies Guide" page.

We use the information and data we collect principally in order to provide our Website and Services. More specifically, we may use your personal information to:

JD Supra takes reasonable and appropriate precautions to insure that user information is protected from loss, misuse and unauthorized access, disclosure, alteration and destruction. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. You should keep in mind that no Internet transmission is ever 100% secure or error-free. Where you use log-in credentials (usernames, passwords) on our Website, please remember that it is your responsibility to safeguard them. If you believe that your log-in credentials have been compromised, please contact us at privacy@jdsupra.com.

Our Website and Services are not directed at children under the age of 16 and we do not knowingly collect personal information from children under the age of 16 through our Website and/or Services. If you have reason to believe that a child under the age of 16 has provided personal information to us, please contact us, and we will endeavor to delete that information from our databases.

Our Website and Services may contain links to other websites. The operators of such other websites may collect information about you, including through cookies or other technologies. If you are using our Website or Services and click a link to another site, you will leave our Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We are not responsible for the data collection and use practices of such other sites. This Policy applies solely to the information collected in connection with your use of our Website and Services and does not apply to any practices conducted offline or in connection with any other websites.

JD Supra's principal place of business is in the United States. By subscribing to our website, you expressly consent to your information being processed in the United States.

You can make a request to exercise any of these rights by emailing us at privacy@jdsupra.com or by writing to us at:

You can also manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard.

We will make all practical efforts to respect your wishes. There may be times, however, where we are not able to fulfill your request, for example, if applicable law prohibits our compliance. Please note that JD Supra does not use "automatic decision making" or "profiling" as those terms are defined in the GDPR.

Pursuant to Section 1798.83 of the California Civil Code, our customers who are California residents have the right to request certain information regarding our disclosure of personal information to third parties for their direct marketing purposes.

You can make a request for this information by emailing us at privacy@jdsupra.com or by writing to us at:

Some browsers have incorporated a Do Not Track (DNT) feature. These features, when turned on, send a signal that you prefer that the website you are visiting not collect and use data regarding your online searching and browsing activities. As there is not yet a common understanding on how to interpret the DNT signal, we currently do not respond to DNT signals on our site.

For non-EU/Swiss residents, if you would like to know what personal information we have about you, you can send an e-mail to privacy@jdsupra.com. We will be in contact with you (by mail or otherwise) to verify your identity and provide you the information you request. We will respond within 30 days to your request for access to your personal information. In some cases, we may not be able to remove your personal information, in which case we will let you know if we are unable to do so and why. If you would like to correct or update your personal information, you can manage your profile and subscriptions through our Privacy Center under the "My Account" dashboard. If you would like to delete your account or remove your information from our Website and Services, send an e-mail to privacy@jdsupra.com.

We reserve the right to change this Privacy Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our Privacy Policy will become effective upon posting of the revised policy on the Website. By continuing to use our Website and Services following such changes, you will be deemed to have agreed to such changes.

If you have any questions about this Privacy Policy, the practices of this site, your dealings with our Website or Services, or if you would like to change any of the information you have provided to us, please contact us at: privacy@jdsupra.com.

As with many websites, JD Supra's website (located at http://www.jdsupra.com) (our "Website") and our services (such as our email article digests)(our "Services") use a standard technology called a "cookie" and other similar technologies (such as, pixels and web beacons), which are small data files that are transferred to your computer when you use our Website and Services. These technologies automatically identify your browser whenever you interact with our Website and Services.

We use cookies and other tracking technologies to:

There are different types of cookies and other technologies used our Website, notably:

JD Supra Cookies. We place our own cookies on your computer to track certain information about you while you are using our Website and Services. For example, we place a session cookie on your computer each time you visit our Website. We use these cookies to allow you to log-in to your subscriber account. In addition, through these cookies we are able to collect information about how you use the Website, including what browser you may be using, your IP address, and the URL address you came from upon visiting our Website and the URL you next visit (even if those URLs are not on our Website). We also utilize email web beacons to monitor whether our emails are being delivered and read. We also use these tools to help deliver reader analytics to our authors to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

Analytics/Performance Cookies. JD Supra also uses the following analytic tools to help us analyze the performance of our Website and Services as well as how visitors use our Website and Services:

Facebook, Twitter and other Social Network Cookies. Our content pages allow you to share content appearing on our Website and Services to your social media accounts through the "Like," "Tweet," or similar buttons displayed on such pages. To accomplish this Service, we embed code that such third party social networks provide and that we do not control. These buttons know that you are logged in to your social network account and therefore such social networks could also know that you are viewing the JD Supra Website.

If you would like to change how a browser uses cookies, including blocking or deleting cookies from the JD Supra Website and Services you can do so by changing the settings in your web browser. To control cookies, most browsers allow you to either accept or reject all cookies, only accept certain types of cookies, or prompt you every time a site wishes to save a cookie. It's also easy to delete cookies that are already saved on your device by a browser.

The processes for controlling and deleting cookies vary depending on which browser you use. To find out how to do so with a particular browser, you can use your browser's "Help" function or alternatively, you can visit http://www.aboutcookies.org which explains, step-by-step, how to control and delete cookies in most browsers.

We may update this cookie policy and our Privacy Policy from time-to-time, particularly as technology changes. You can always check this page for the latest version. We may also notify you of changes to our privacy policy by email.

If you have any questions about how we use cookies and other tracking technologies, please contact us at: privacy@jdsupra.com.

See the original post here:
2020 Legislative Session A Sampling of Health Related Bills Filed - JD Supra

Job Description

Junior Research Fellow (JRF)for Translational Research - Stem Cell-based Neural Tissue Engineering Project:

Title of the Project: Human dental pulp stem cells as a multifaceted tool for accelerating neural regenerationDuration: 3 YearsLocation: Vellore Institute of Technology, Vellore

Qualification:

M.Sc/ M. Tech (Biomaterials, Tissue Engineering, Biotechnology, Biology, and Biomedical Sciences) with a minimum of 55% marks.

Skill set required:

Candidate with work experience in biomaterial synthesis, scaffold fabrication and stem cell culture is desirable.

Stipend: Rs.20,000/- per month (consolidated)

Work functions of the JRF: The JRF will be required to do full time research related to this specific project, in particular biomaterial synthesis and characterization, scaffold fabrication, biological assays, dental stem cell culture.

Principal Investigator:

Dr.Murugan RamalingamCentre for Biomaterials, Cellular and Molecular Theranostics (CBCMT)School of Mechanical EngineeringVellore Institute of Technology (VIT),Vellore 632014

Send your resume along with relevant documents pertaining to the details of qualifications, experience and latest passport size photo on or before (30/11/2019) through online http://careers.vit.ac.in.

No TA and DA will be paid for appearing for the interview.

Shortlisted candidates will be called for an interview at a later date which will be intimated by email.

Salary:Not Disclosed by RecruiterIndustry:Education / Teaching / TrainingFunctional Area:Teaching, Education, Training, CounsellingRole:Trainee

Keyskills

stem cellsbiotechnologybiologybiomaterials

Desired Candidate Profile

Please refer to the Job description above

Education-

UG:B.Tech/B.E. - Bio-Chemistry/Bio-Technology, Biomedical, B.Sc - BiologyPG:M.Tech - Bio-Chemistry/Bio-Technology, Biomedical, MS/M.Sc(Science) - Biotechnology, Biology

Company Profile

Vellore Institute of Technology

VIT was established with the aim of providing quality higher education on par with international standards. It persistently seeks and adopts innovative methods to improve the quality of higher education on a consistent basis.The campus has a cosmopolitan atmosphere with students from all corners of the globe. Experienced and learned teachers are strongly encouraged to nurture the students.

Link:
Junior Research Fellow for Stem Cell-Based Neural Tissue Engineering Project job with VELLORE INSTITUTE OF TECHNOLOGY | 187070 - Times Higher...

The tooth is a biological organ and consists of multiple tissues including the cementum, dentin, enamel, and pulp. Dental caries, Periodontal disease, and tooth fracture are the three main factor for tooth loss. Tooth Regeneration is the specialty concerned with the treatment of dental diseases such as a cavity, periodontal disease and fracture of the tooth. Dental caries is also known as tooth decay is the main oral health problems in most of the industrialized countries. Facial trauma also the major cause of tooth loss. Tooth loss leads to people mentally and physically disturb and it also affect the self-confidence and quality of life. Tooth regeneration is the process of individual tissue and the whole tooth development. Basically, it is the process of restoring the loss of natural teeth. Tooth regeneration is stem cell-based regenerative medical procedure which is used in stem cell biology sector and tissue engineering. There are two approaches used in the build of new whole teeth, in vivo implantation of tooth germ cells which were previously generated from stem cells and grow in vitro cells and another organotypic culture is an appropriate technique for the generation of teeth. The process of tooth regeneration imitates the natural tooth development using stem cells. In another way instead of whole teeth regeneration, Different part of the teeth regenerates such as Enamel regeneration, Dentin regeneration, Pulp regeneration, and periodontal regeneration.

Globally increasing incidence and prevalence of dental problems such as a cavity, periodontal disease, and tooth fracture are the major factors driving the growth of the Tooth Regenerations market. Innovative new techniques in Tooth regeneration such as cell homing, cell transplantation is expected to increase the acceptance of Tooth Regenerations. Tooth regeneration not only regrowth the entire tooth but also the restoration of individual components of the tooth such as dentin, cementum, enamel and dental pulp and these individual regeneration process is anticipate the boost the market growth of tooth regeneration market. Dental implantation also increases the growth of tooth regeneration market. People are very keen interested in the tooth regeneration and they are also giving more importance to the aesthetic aspects of dental products, which is expected to increase the Tooth Regenerations and dental market over the forecast period. The increasing demand for a customized Tooth Regeneration with the specifications and other dental decorative installations is the key factor anticipated to propel the demand for Tooth Regenerations worldwide.

The Global Tooth Regenerations market is segmented on the basis of application, Demographics, technique and by End user

Based on the Application type Tooth Regenerations market is segmented as:

Based on the Demographic Tooth Regenerations market is segmented as:

Based on the Technique, Tooth Regenerations market is segmented as:

Based on the end user Tooth Regenerations market is segmented as:

According to WHO, approx.30% the geriatric population is affected by the complete loss of teeth. Rapidly increasing Dental cavities and periodontal diseases are the major drivers in the Tooth Regenerations market. The global Tooth Regenerations market by application is expected to be dominated the market of Tooth Regenerations, out of which Enamel segment is expected to generate maximum revenue share over the forecast period. By end user, Tooth Regenerations market is expected to be dominated by dental clinics and hospitals. The manufacturers in the concerned market are focusing on manufacturing advanced products for better patient compliance and make the procedure easier. The market of tooth regeneration is anticipated to boost by stem cell regeneration technology.

The global Tooth Regenerations market is expected to be dominated by North America due to higher adoption and significant geriatrics population which also increase the demand for dental service for Dental caries and Periodontal disease. Europe is expected to be the second most lucrative Tooth Regenerations market due to rising funds for research for the growing patient population. Asia-Pacific is expected to be the fastest growing Tooth Regenerations market due to rapidly increasing incidence of dental surgery, general prosthetic fixation. Latin America and Middle East & Africa are expected to be the least lucrative market due to Low awareness regarding the use of Tooth Regenerations technology and comparatively less developed healthcare infrastructure in major regions.

Examples of some of the market participants in the global Tooth Regenerations market identified are DENTSPLY Implant, Unilever, Datum Dental, Institut Straumann AG, Keystone Dental, Inc., Zimmer Biomet, Wright Medical Group N.V., Integra LifeSciences, CryoLife, Inc, BioMimetic Therapeutics, Inc, Cook Group and among others.

Read more:
Tooth Regenerations Market: Global Industry Trend Analysis 2013 to 2017 and Forecast 2018 2026 - Statsflash

Stem Cell Banking Market 2019 Industry report provides detailed statistics and accurate market figures, viz. market share, CAGR, gross margin, and those related to revenue, production, consumption, and sales. It also provides a regional analysis of the global Stem Cell Banking market to unveil key opportunities available in different parts of the world. This all analyzed data will help a new player and existing players to take a critical decision.

Get Sample Copy of this Report @ https://www.orianresearch.com/request-sample/1369382

The key players profiled in the market include: Cord Blood Registry Systems, Cordlife, Cryo-Cell International, Cryo-Save AG, LifeCell International, StemCyte, ViaCord, Global Cord Blood, Smart Cells International and Vita34

The global Stem Cell Banking market was estimated to be valued at USD XX million in 2018 and is projected to reach USD XX million by 2026, at a CAGR of XX% during 2019 to 2026. Growing awareness on the therapeutic potential of stem cells coupled with the increasing investments in stem cell-based research will aid in augmenting the market growth. However, high operational costs of stem cell banking and stringent regulations will impede the market growth during the analysis period.

The global stem cell banking market is segmented on the basis of source, application, service type and region. Based on source the market is segmented into Placental Stem Cells (PSCs), Human Embryo-derived Stem Cells (hESCs), Bone Marrow-derived Stem Cells (BMSCs), Adipose Tissue-derived Stem Cells (ADSCs), Dental Pulp-derived Stem Cells (DPSCs) and other stem cell sources. Based on application the market is segmented into personalized banking applications, clinical applications, hematopoietic disorders, autoimmune disorders, other diseases, research applications, disease treatment studies, life science research and drug discovery. Based on service type the market is segmented into sample collection & transportation, sample processing, sample analysis and sample preservation & storage. Based on region, it is studied across North America Europe, Asia-Pacific, South America and Middle East and Africa.

No of Pages: 121

Key Benefits of the Report:

* Global, regional, by type, storage capacity, and by end user wise market size and their forecast from 2015-2026

* Identification and detailed analysis on key market dynamics, such as, drivers, restraints, opportunities, and challenges influencing growth of the market

* Detailed analysis on product outlook with market specific Porters Five SSDs analysis, PESTLE analysis, and Value Chain, to better understand the market and build expansion strategies

* Identification of key market players and comprehensively analyze their market share and core competencies, detailed financial positions, key product, and unique selling points

* Analysis on key players strategic initiatives and competitive developments, such as joint ventures, mergers, and new product launches in the market

* Expert interviews and their insights on market shift, current and future outlook, and factors impacting vendors short term and long term strategies

* Detailed insights on emerging regions, by type, storage capacity, and by end user with qualitative and quantitative on premise and facts

The encrypted hard drives market is primarily segmented based on type, by storage capacity, by end user, and region.

Order a copy of Global Stem Cell Banking Market Report @ https://www.orianresearch.com/discount/1369382

On the basis of source, the market is split into:

* Placental Stem Cells (PSCs)

* Human Embryo-derived Stem Cells (hESCs)

* Bone Marrow-derived Stem Cells (BMSCs)

* Adipose Tissue-derived Stem Cells (ADSCs)

* Dental Pulp-derived Stem Cells (DPSCs)

* Other Stem Cell Sources

Based on end user, the market is divided into:

* Personalized Banking Applications

* Clinical Applications

* Hematopoietic Disorders

* Autoimmune Disorders

* Other Diseases

* Research Applications

* Disease Treatment Studies

* Life Science Research

* Drug Discovery

On the basis of service type, the market is split into:

* Sample Collection & Transportation

* Sample Processing

* Sample Analysis

* Sample Preservation & Storage

These enterprises are focusing on growth strategies, such as, technological advancements, expansions, acquisitions, and agreements & partnerships to expand their operations across the globe.

Target Audience:

* Stem Cell Banking Manufacturers

* Industry Participants and Associations

Research Methodology:

The market is derived through extensive use of secondary, primary, in-house research followed by expert validation and third party perspective, such as, analyst reports of investment banks. The secondary research is the primary base of our study wherein we conducted extensive data mining, referring to verified data sources, such as, white papers, research and regulatory published articles, technical journals, trade magazines, and paid data sources.

For forecasting, regional demand & supply factors, recent investments, market dynamics including technical growth scenario, consumer behavior, and product trends and dynamics, and product capacity were taken into consideration. Different weightages have been assigned to these parameters and quantified their Market impacts using the weighted average analysis to derive the Market growth rate.

The market estimates and forecasts have been verified through exhaustive primary research with the Key Industry Participants (KIPs), which typically include:

* Manufacturers

* Suppliers

* Distributors

* Government Body & Associations

* Research Institutes

About Us:

Orian Research is one of the most comprehensive collections of market intelligence reports on the World Wide Web. Our reports repository boasts of over 500000+ industry and country research reports from over 100 top publishers. We continuously update our repository so as to provide our clients easy access to the worlds most complete and current database of expert insights on global industries, companies, and products. We also specialize in custom research in situations where our syndicate research offerings do not meet the specific requirements of our esteemed clients.

Contact Us:

Ruwin Mendez

Vice President Global Sales & Partner Relations

Orian Research Consultants

US: +1 (832) 380-8827 | UK: +44 0161-818-8027

Email: [emailprotected]

Website: http://www.orianresearch.com/

Go here to see the original:
Stem Cell Banking Market Size, by Source (Placental Stem Cells), by Application (Personalized Banking Applications), by Service Type (Sample...

LONDON--(BUSINESS WIRE)--The global cell separation market is poised to grow by USD 7.12 billion during 2020-2024, progressing at a CAGR of over 17% during the forecast period. Request Free Sample Pages

Read the 142-page research report with TOC on "Cell Separation Market Analysis Report by End-User (Academic institutions and research laboratories; Pharmaceutical and biotechnology companies; and Hospitals and clinical testing laboratories), by Geography (North America, Europe, Asia, and ROW), and Segment Forecasts, 2020 - 2024"

The market is driven by the increasing use of cell separation in cancer research. In addition, the rising focus on personalized medicine is anticipated to further boost the growth of the cell separation market.

The increasing use of cell separation in cancer research will be one of the major drivers in the global market. Over the last few years, cell separation has been used along with imaging, proteomics, and molecular biological methods to identify and characterize cancer stem cells. This helps in the early diagnosis of tumors, monitoring of circulating tumor cells, and evaluation of intratumor heterogeneity. Also, the incidence of cancer is increasing rapidly, especially amongst women. Cervical and breast cancers are the most common types in the world. The rising incidence of cancer is encouraging further research in the field. Moreover, advances in computer techniques, optics, and lasers introduced a new generation of cell separation techniques which are capable of high speed processing of single cell suspensions. These factors will boost the global cell separation market growth during the forecast period of 2020-2024.

Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.

View market snapshot before purchasing

Major Five Cell Separation Market Companies:

Akadeum Life Sciences

Akadeum Life Sciences owns and operates the businesses under various segments such as T cell isolation kits, B cell isolation kits, red blood cell products, Streptavidin products, and CD45 products. The product offered by the company is human T Cell isolation kit. This product uses streptavidin-conjugated BACS microbubbles and biotinylated antibodies for cell separation.

Becton, Dickinson and Co.

Becton operates the business under three segments, which include BD medical, BD life sciences, and BD interventional. The companys key offering include the BD IMag cell separation magnet. This product is used to attract labeled cells to the adjacent walls of tubes, allowing the removal of the supernatant, which contains unlabeled cells.

Bio-Rad Laboratories Inc.

Bio-Rad Laboratories Inc. has business operations under various segments, namely life science and clinical diagnostics. The product offered by the company is the ddSEQ single-cell isolator. This product is offered as an automated device to process hundreds to tens of thousands of cells per day.

Cell Microsystems, Inc.

Cell Microsystems, Inc. operates the business under three segments, which include CellRaft AIR System, CytoSort Array, and CellRaft System for inverted microscopes. The companys key offerings include the CellRaft AIR System. This product is available with an automated precision X-Y stage and a microscope with three-channel fluorescence imaging capabilities. It is designed to reduce the time taken for cell separation.

Danaher Corp.

Danaher Corp. operates the business through the following segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions. The companys key offering in the cell separation market include Avanti J-26S XP. This product is offered as a centrifuge, which includes the elutriation particle separation functionality.

Register for a free trial today and gain instant access to 10,000+ market research reports.

Technavio's SUBSCRIPTION platform

Cell Separation End-User Outlook (Revenue, USD Million, 2020 - 2024)

Cell Separation Regional Outlook (Revenue, USD Million, 2020 - 2024)

Technavios sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report

Related Reports on HealthCare are:

Cell Isolation Market Global Cell Isolation Market by product (consumables and instruments), end-users (AR, PB, CRO, and others), and geography (Asia, Europe, North America, and ROW).

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavios report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavios comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

If you are interested in more information, please contact our media team at media@technavio.com.

Read the original:
Global Cell Separation Market 2020-2024 | Evolving Opportunities with Akadeum Life Sciences and Becton, Dickinson and Co. | Technavio - Business Wire

Stem Cell Banking Market Global Drivers, Restraints, Opportunities, Trends, and Forecasts: 20192026Overview: Stem cells are undifferentiated biological cells that can distinguish into specialized cells, tissue, or an organ. The process of storing these stem cells for the treatment of life-threatening diseases in the future is called stem cell banking. Nearly 500 stem cell banks are functioning globally, and every bank is now striving harder to increase their market share. Stem cell banking has applications in cerebral palsy, thalassemia, leukemia, diabetes, autism, and others. Cerebral palsy holds the major share of nearly quarter of the market share among the various applications. Private stem cell banks are implementing innumerable publicizing strategies to upsurge their product visibility among people.

Key Players: Esperite, Caladrius Biosciences, Via Cord, CBR Systems, Smart Cells, Life Cell, China Cord Blood, Cryo-Cell, StemCyte, Cordvida, ViaCord, Cryoviva, and other predominate & niche players.

Get Sample copy of this Report: http://contrivedatuminsights.com/Home/RequestaSample/2433

The market is driven by factors such as easy method of extraction of stem cells from the samples, increasing birth rate, increased awareness of stem cell therapeutics, and increasing potentials of stem cell treatment. Alongside, the collaboration among the cord blood banks, increasing investments and fundings, and automation of procedures for the banking of stem cells are providing opportunities for the growth of the stem cell banking market. However, intense competition, high operating costs, changes in legal regulations, and high entry barriers are the major factors hampering the market growth.

Market Analysis: The Stem Cell Banking Market is estimated to witness a CAGR of 16.4% during the forecast period 20192026. The market is analyzed based on three segments, namely product types, end-users, and regions.Regional Analysis: The regions covered in the report are North America, Europe, Asia Pacific, and Rest of the World (RoW). North America is set to be the leading region for the stem cell banking market growth followed by Europe. Asia Pacific and RoW are set to be the emerging regions. India, China, and Japan are set to be the most attractive destinations due to the large untapped market.

Product Types Analysis: The stem cell banking market by products is segmented into umbilical cord blood & cord tissue, and adult stem cell banking. The umbilical cord blood & tissue occupies the major share in the market and is also expected to grow at a fast CAGR during the forecast period. The dental stem cell banking and menstrual blood stem cell banking are the latest diversifications in the stem cell banking market. The market is also witnessing various mergers, acquisitions, and collaborations among the top players, which is defining the future of the global stem cell banking market.

Get Special Pricing: http://contrivedatuminsights.com/Home/GetSpecialPricing/2433

Competitive Analysis: These days, stem cell banks exist in most of the developed and developing nations. Around 450 companies are publicizing cord blood banking services internationally, which signifies intense competition in the market. Globally, China Cord Blood Corporation (CCBC) is expected to be the fastest growing stem cell bank worldwide and in the US, it is Amricord. In 2014, the company Amricord achieved 2,200% growth rate from 2011-2013. Future Health Biobank, American Cryostem, Adicyte, Adisave, Celltex, and Vault Stem currently hold around two-thirds of the Mesenchymal Stem Cells (MSC) storage market. However, at present, these companies are still trivial but are swiftly intensifying. Cryostem witnessed its revenue to nearly double in 2016 from $400,000 to almost $800,000.

Benefits: The report provides complete details about the usage and adoption rate of stem cell banking in various regions. With that, key stakeholders can know about the major trends, drivers, investments, vertical players initiatives, government initiatives toward the stem cell therapy and banking adoption in the upcoming years along with the details of commercial devices available in the market. Moreover, the report provides details about the major challenges that are going to impact on the market growth. Additionally, the report gives complete details about the key business opportunities to key stakeholders to expand their business and capture the revenue in the specific verticals to analyse before investing or expanding the business in this market.

For More Information: http://contrivedatuminsights.com/Home/InquiryBeforeBuying/2433

Table of Contents

Global Stem Cell Banking Market Research Report

Chapter 1 Global Stem Cell Banking Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export

Chapter 6 Production, Revenue (Value), Price Trend by Type

Chapter 7 Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Market Forecast

Any special requirements about this report, please let us know and we can provide custom report.

Read the rest here:
Stem Cell Banking Market Size, Share, Growth, Future Prospects, Competitive Analysis and Forecast To 2026 - Med News Ledger

According to a latest report published by Global Marketers Biz named as Mesenchymal Stem Cells Market offers data for the forecast period 2019-2024. A comprehensive research updates and data which includes following key aspects for the global Mesenchymal Stem Cells Market in terms of volume and revenue Visitor Demographics, Facility Size, Demand & Growth Opportunities, Global Industry Forecast Analysis and Revenue Source.

The Mesenchymal Stem Cells Market report offers in-depth analysis and insights into developments impacting businesses and enterprises on global & regional level. A detailed breakdown of key trends, drivers, restraints, and opportunities influencing revenue growth is presented in this research report. This study focuses on the global Mesenchymal Stem Cells market by share, volume, value, and regional appearance along with the types and applications.

Request a free sample report on Mesenchymal Stem Cells market @https://www.globalmarketers.biz/report/medicine/global-mesenchymal-stem-cells-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130812#request_sample

Please Note :This Report can be dispatched within 24 Hours

Key Players of Mesenchymal Stem Cells Report are:

LonzaThermo FisherBio-TechneATCCMilliporeSigmaPromoCell GmbHGenlantisCelprogenCell ApplicationsCyagen Biosciences

Market is Segmented into below points:

Market by Type/Products:

Human MSCMouse MSCRat MSCOther

Market by Application/End-Use:

Research InstituteHospitalOthers

Market by Region:

For Discount on this report please visit @ https://www.globalmarketers.biz/report/medicine/global-mesenchymal-stem-cells-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130812#inquiry_before_buying

Some of the major areas of this report:

Request for Customized Report:https://www.globalmarketers.biz/report/medicine/global-mesenchymal-stem-cells-market-2019-by-company,-regions,-type-and-application,-forecast-to-2024/130812#inquiry_before_buying

About Global Marketers Biz:

Global Marketers is a research eye which discovers the syndicate, custom and consulting research needs. The company surpasses in catering to the research requirements of commercial, industrial and all other business enterprises. Surgical market analysis followed by Comprehensive research methodology will drive the businesses in planning & reshaping the business schemes and the growth of industry. The company also offers research reports related to chemical, healthcare, technology, automobile and several other sectors. This is the trustworthy brand when talked about quality survey and highly reachable to customer requirements of any industry situated across the globe.

For any additional questions get in touch with,

Mr. Alex White

Email: [emailprotected]

Phone number: +1(617)2752538

Website: https://www.globalmarketers.biz/

Read the original:
Global Mesenchymal Stem Cells Market Forecast, by regions, type and application, with sales and revenue, from 2019 to 2024. - Montana Ledger

PRP, or platelet-rich plasma, is part of a revolution in medicine. PRP contains an abundance of growth factors that play a valuable role in healing many ailments. The PRP technology has been developing for the benefit of patients, resulting in improved outcome and great results.

Platelet-rich plasma has evolved over the past 15 years from an experimental treatment and an idea that concentrated platelets can heal injuries to an everyday treatment that benefits so many. Platelets are concentrated by taking your blood in a tube or syringe and spinning the blood in a high-speed centrifuge that causes the components of blood to separate, including the red blood cells, white blood cells and platelets. The first generation of platelets involved one or two spins to separate the platelets, often including an anticoagulant to prevent clotting and solidifying of the platelets so it can be spread as a liquid around the target. This PRP has been effective for a range of musculoskeletal conditions. The second generation of PRP involves formation of a platelet-rich fibrin matrix (PRFM) that is valuable as a gel that can be applied to wounds, surgical sites and for dental conditions.

The third generation of PRP, also called CGF or concentrated growth factors,

was first developed and described in 2006 by an Italian physician (Dr. Sacco) and has recently become widely available in the United States with the Medifuge centrifuge. With a single spin, the blood is spun at multiple speeds, which concentrates the platelets while also isolating cells that express CD34+. This is a type of stem cell that greatly enhances the effectiveness of the platelets. The other advantage of this third-generation PRP is that without anticoagulants the platelets can be applied quickly as a liquid to apply to injured tendons and ligaments or for cosmetic benefit. By waiting a few minutes the platelets solidify, which is great for applying to wounds. Even when applied as a liquid, the third generation platelets solidify soon after injected, which helps attach the platelets to the area injected. This allows the platelets to provide growth factors for a longer duration to increase effectiveness.

There are many applications for this advanced PRP. Ligament and tendon injuries respond very well to PRP. These injuries often do not heal spontaneously because the ligaments and tendons do not get good blood flow. With PRP and its accompanying growth factors, the tendon and ligament is able to finally heal, providing long-term relief. In contrast to a steroid injection, which provides short-term relief and may contribute to tissue degeneration, PRP helps build and strengthen tissue and provides long-term relief.

To clarify, tennis elbow, golfers elbow, rotator cuff tendonitis, wrist tendonitis, iliotibial band syndrome, Osgood-Schlatters and Achilles tendonitis are all examples of tendon injuries characterized by weakening of the tendon fibers or even partial tears. PRP strengthen the tendon and heals all of these conditions.

Ligament injuries include all joint sprains and strains such as ankle sprains, shoulder strains, etc. The hallmark of joint arthritis is weakening of the ligaments that leads to wear and tear of the joint, with a cascade of cartilage erosion that leads to bone spurs, then joint space narrowing and eventually bone on bone. Any time you see a bone spur, chances are that there is a loose ligament that created the conditions that led to that spur. Platelets heal the ligaments so that the joint is more stable and the arthritic pain is relieved and recurrent ankle sprains stop recurring.

Thus, PRP is very effective for arthritic joints, including knee arthritis, hip arthritis and shoulder arthritis among others. The PRP is effective at strengthening the joint capsule that is comprised of ligaments and can provide support for the joint cartilage. Even with severe bone-on-bone arthritis, PRP can help strengthen the ligaments around the joint, which helps reduce pain.

PRP can also help you improve your appearance. With the vampire facial you get the benefit of the healing growth factors, which lead to increased collagen and blood flow for skin rejuvenation. The great aspect of this treatment is that this is a very natural way to naturally enhance your skin. Without undergoing surgery you can achieve a youthful appearance. So while stars such as Bar Rafaeli and Kim Kardashian have used platelets to enhance their appearance, the vampire facial is accessible to you and will give your skin a healthy, revitalized feeling. Everyone has an inner beauty. PRP helps your outer beauty so it is in sync with your inner beauty.

There are other cosmetic benefits to platelets. The growth factors that the platelets release can heal scars. This includes unsightly scars after a surgery or a laceration. Growing collagen within the scar will usually improve its appearance. Acne scars, which are tiny holes along the skin surface, are filled in with platelets. Burn scars may not be totally eliminated with PRP, but the growth factors can have dramatic effects on the appearance of these scars.

Another cosmetic benefit of PRP is hair growth. PRP leads to increased hair follicle formation increasing the hair density. While not practical for total hair loss, PRP is excellent for treating thinning hair in men and women. The best part is that you are stimulating the follicle growth with your own platelets without the use of medications or other invasive procedures. So if you run your hand through your hair and you feel it is thinner than you would like, PRP may be for you.

PRP is abundant, safe and the worlds most sophisticated repair system. Nothing else comes close to its amazing properties. PRP is a powerful source of growth factors. Whats best is that it comes from your own body so you are healing your own body with your own platelets. Whether you have an injury that needs the healing benefit of platelets, or if you want to enhance your appearance, promote hair growth or improve a scar, or for other challenges that can be enhanced with platelets, you should consider PRP to improve your quality of life. The success of PRP has been enhanced with the new technology of third-generation PRP. The concentrated growth factors (CGF) optimize platelets that are enhanced by stem cells for maximal benefit.

Dr. Slaten is a pain wellness physician in Ridgewood. For more than 20 years he has been practicing regenerative techniques with great skill and an open mind. Check out his website at http://www.njprp.com for more information.

See the article here:
The Third Generation of PRP Is Here - Jewish Link of New Jersey

While the spotlight has lately been on dengue, polio and other virus-borne diseases, the most widespread illness in childrenfive times more prevalent than asthmacontinues to affect many kids. Im talking about early tooth decay.

Cavities? No big deal, kids get them, their baby teeth will fall out anyway, right?

No, its a disease. Cavities are triggered by bacteria that use sugar to make acids that damage teeth. It erodes the structure of teeth by draining off the calcium. Even without causing pain, decaying baby teeth could mean rotten permanent teeth.

When permanent teeth come into an environment where the baby teeth have already decayed, the same bacteria will attack the new teeth, said Burton Edelstein, DDS, MPH, professor of dentistry and health policy at Columbia University.

There are more cases of early tooth decay partly because kids are eating more processed food like pretzels, crackers, sweets, juice and soda than before. Gummy candy/vitamins are also to blame.

Kids need their parents to brush and floss their teeth for them until theyre 6 because they cant do it well yet. They tend to brush the same teeth in the front over and over again, but dont get to the back teeth or the inside surfaces, said Paul Casamassimo, DDS, chief of dentistry at Nationwide Childrens Hospital in Columbus, Ohio.

Mary Lynn R. Abellera, DMD, pediatric dentist at Dental Nook Santana Grove Sucat, is more conservative: Usually at 8-9 years old they have already developed the dexterity to brush their own teeth. Thats right along the time when theyre adept enough to tie their own shoes.

I let my feisty 4-year-old daughter brush her teeth by herself, but I follow up with an inspection, going over it again. We then add a tongue scraping to get rid of bad breath-causing gunk.

Its a great time to also introduce flossing, as its the only way to reach the cavity-causing plaque between teeth and below the gums.

Loose tooth

What to do when a child starts having a loose tooth? Parents should condition the child that they will lose a tooth because theres a new one coming out. Encourage the child to use the tooth in biting and brush it properly so it will wiggle more, said Abellera.

Tempting as it may be, dont yank it out. Said Grace Yum, DDS, a pediatric dentist at Childrens Memorial Hospital Chicago: Its better to let it come off on its own. Removing it early can be painful and may cause gum infection. Most kids are fascinated with wiggling a loose tooth and thats okay, but be certain her hands are clean.

What about when a child complains of pain during tooth development? Generally, an erupting tooth does not cause pain, but if it does, see a dentist. In the meantime, its safe to give paracetamol, advised Abellera.

With new permanent teeth in place, how else can we take better care of them? Ask your dentist to apply dental sealants, plastic coatings that can lower the chances of decay by about 89 percent.

Molar erosion

My 8-year-old son grinds his teeth in his sleep. This has led to the erosion of his molars, which makes biting painful. Since my son is too young to be fitted for a mouth guard, his bite is raised by applying a composite (pasta or filling) on the applicable surfaces every few months, depending on the severity of the erosion.

Night grinding or bruxism is an unconscious habit. It is a sleep-related movement disorder. There is still no concrete cause but its usually a combination of psychological, genetic and physical factors, explained Abellera. Sometimes thats how the child releases stress. Some grinders dont need treatment, but they can wear night guards to protect their teeth.

For parents who can afford it, cord blood banking is considered for its stem cell possibilities.

What about tooth banking?

Said Abellera: Tooth banking is saving or storing baby teeth, wisdom teeth or healthy extracted teeth for regenerative medicine. The dentist will extract the tooth at a certain time to preserve the vitality of the pulp, then it will be stored properly and be collected by the tooth bank. Like insurance, theres an annual cost for storage.

Teeth are an excellent source of stem cells, the dental pulp, especially if its a young permanent tooth. Since regenerative therapies are on the rise, tooth banking is gaining popularity. However, its still not prominent in the Philippines. Usually its used only for autogenous grafting for dental implants, not for regenerative therapies.

Looks like the tooth fairy is still in business. CONTRIBUTED

Read more from the original source:
Why you need to brush and floss your kid's teeth until he's 6 - INQUIRER.net

Latest Survey on Silicon Steel Sheet Market:

The Silicon Steel Sheet Market research report 2019-2026 provides the newest industry data and industry future trends, allowing you to identify the products and end users driving Revenue growth and profitability.Silicon Steel Sheet market report helps businessman/investor avoiding unpleasant surprises. Intuition and experience can be helpful at times, but research and facts often paint a more accurate picture of your market.

This study categorizes the global Silicon Steel Sheet breakdown data by manufacturers, region, type, and application, also analyzes the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, distributors.

Major key-companies of this report: SSMC, Severstal, POSCO, JFE Steel, AK, CSC, Acroni, C.D. W Lzholz, TATA, Mapes & Sprowl, SESS, Arnold Magnetic Technologies, ThyssenKrupp AG, MARTIN MARIETTA MAGNESIA, ERDEMIR ROMANIA, Baosteel, WISCO, Ma Steel, An Steel, Tisco, Valin

Request a customized copy of Silicon Steel Sheet report: https://www.acquiremarketresearch.com/sample-request/226920/

Silicon Steel Sheet Market

Silicon Steel Sheet Market Based on Types: Oriented Electrical Steel, Non-Grain Oriented Electrical Steel

Silicon Steel Sheet Market Based on Applications: Transformers, Generators, Electric Motor, Others

The report serves a professional and detailed study of the latest key business trends, major drivers responsible for the growth of Silicon Steel Sheet market as well as constraints that can hamper the growth. It provides a complete analysis of major players, segmentation and forecast analysis. It serves a comprehensive view of size; trends and aspect have been included in this report to analyze factors that will perform a momentous impact in propelling the sales of Silicon Steel Sheet market.

Use Corporate ID to avail Discount on this Silicon Steel Sheet Market Report report: https://www.acquiremarketresearch.com/discount-request/226920/

Regional Analysis For Silicon Steel Sheet Market

North America (the United States, Canada, and Mexico)Europe (Germany, France, UK, Russia, and Italy)Asia-Pacific (China, Japan, Korea, India, and Southeast Asia)South America (Brazil, Argentina, Colombia, etc.)The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, and South Africa)

Here are the important points covered in the report:

Complete assessment of opportunities and risk factors involved in the growth of Silicon Steel Sheet Market. Additionally, major events and innovations in Silicon Steel Sheet Market report. Technological advancements and changing trends striking Silicon Steel Sheet Market. Get to know about the leading market players, both current and emerging in the Global Silicon Steel Sheet. The report focuses on global major leading Silicon Steel Sheet Market players providing information such as company profiles, product picture, and specification, capacity, production, price, cost, revenue and contact information.

Reasons to Buy This Research Report

Key trends, drivers and restraints for globalSilicon Steel Sheet Market.

To comprehend the future standpoint and prospects of Market.

The Silicon Steel Sheet Market Production Analysis with respect to different regions, types, and applications.

To identify the latest developments, market shares, and strategies employed by the major Market players.

The intensive approach towards Silicon Steel Sheet market drivers, constraints, chances, and trends moving the market can assist to create spectacular business plans.

Get Full Report Description, TOC, Table of Figures, Chart, etc. @ https://www.acquiremarketresearch.com/industry-reports/silicon-steel-sheet-market/226920/

The evaluations featured in the report have been derived using appropriate research methodologies and conclusion. By doing this, the Silicon Steel Sheet Market research report offers a reservoir of study and data for every aspect of the market.

Read more:
Global Stem Cell Assay Market is anticipated to grow at a 19.9% CAGR from 2019 to 2030 - Health News Office

Teeth are the foremost natural, noninvasive source of stem cells. Dental stem cells, that are straightforward, convenient, and reasonable to gather, hold promise for a variety of very potential therapeutic applications. Dental stem cells provide an awfully promising therapeutic approach to restoring structural defects and this idea is extensively explored by many researchers that are obvious by the speedily growing literature in this field.

Dental problems caused by dental caries, periodontal disease and tooth injury compromise the oral and general health issues. Current advances in the development of regenerative therapy have been influenced by our understanding ofembryonic development, stem cell biology, and tissue engineering technology.Tooth regenerationis a field of regenerative medicine procedure within the field of tissue engineering and stem cell biology to exchange damaged or lost teeth by re-growing them from autologous stem cells.

Dental stem cells and cell-activating cytokines are thought to be candidate approach for tooth tissue regeneration as results of they have the potential to differentiate into tooth tissues in vitro and in vivo. Whole tooth replacement therapy is taken into consideration to be an attractive idea for next generation regenerative therapy as a type ofbioengineered organ replacement.Dental problems caused by dental caries, periodontal disease and tooth injury compromise the oral and general health issues. Current advances in the development of regenerative therapy have been influenced by our understanding of embryonic development, stem cell biology, and tissue engineering technology.Tooth regenerationis a field of regenerative medicine procedure within the field of tissue engineering and stem cell biology to exchange damaged or lost teeth by re-growing them from autologous stem cells.

Dental stem cells and cell-activating cytokines are thought to be candidate approach for tooth tissue regeneration as results of they have the potential to differentiate into tooth tissues in vitro and in vivo. Whole tooth replacement therapy is taken into consideration to be an attractive idea for next generation regenerative therapy as a type of bioengineered organ replacement.

Source:https://tissuesciencecongress.conferenceseries.com/

See the rest here:
Dental Stem Cells and Tooth Regeneration In 2019 celldent

For the last decade now we have been promised the advent of dental stem cell therapy to help regrow our missing teeth. With the growth and expansion of newer technologies like dental implants, and advances in root canal therapy, the talk of stem cells has subtly taken a back seat. The question remains: how far away are we from stem cells actually impacting the dental market?

Sungtao Shi, professor and chairman at the University of Pennsylvania department of Anatomy and Cell Biology, is at the forefront of this research and he is showing how close we may actually be to this new form of treatment.

Professor Shi has been working for the past ten years testing the possibilities of dental stem cells after discovering them in his own childs baby tooth. His team has learned more about how these dental stem cells work, and how they could be safely be used to regrow dental tissue, known as pulp (this is the tissue that we see within our teeth).

Dental Stem Cell Therapy

Shi along with David Mooney (Professor of Bioengineering at Harvard University) are making claims that these stem cells can be directly placed within our dental pulp to help regrow parts of a tooth that have been damaged by decay.

Several other researchers have also chimed in getting similar results in their own laboratories. Paul Sharpe, a leading bioengineer at Kings County London, has noted that his lab findings indicate mobilizing dental stem cells into our own pulp helps regrow lost dentin. He claims that the new dentin that is formed completely fuses with our own healthy dentin.

Sharpe has also add that this form of tissue engineering could be the first real advance in dental pharmaceuticals, and that we could see this on the market very soon.

The question that this form of therapy poses is this: how much of these stem cells need to be synthesized and given to each individual? The amount will be critical as too much may lead to serious side effects in people. Clinical trials will need to be conducted to see what amount of the agent is safe.

Sharpe is now investigating larger groups of potential agents to determine which stem cell therapy works best for decaying teeth and also working on the optimal dose.

Sharpes team is also working on a new delivery system, which is more practical to modern dental clinics: The chosen agent of stem cells will be dissolved in gel-form, and is injected directly into a cavity and bathed with ultraviolet light until it has solidified. This is a quick and easy procedure for any trained dentist.

Dental Stem Cells

The hope is to properly introduce newer stem cell treatments into modern dentistry, although, researchers still need to perform clinical trials with human patients for efficacy and safety standards.

Some of the dental stem cell treatments are currently being considered to be approved for other uses in humans, which he hopes will expedite the process for eventual FDA approval. A lot of dental treatments are still in the dark ages, Sharpe says. Its time to move forward.

We find ourselves in a revolutionary time in the field of dentistry. Over the next decade we will hopefully see newer agents like these enter the market and make a significant impact on our communities. This new stem cell technology will hopefully also reduce the sky-rocketing prices of certain other dental procedures.

Ultimately, we will have to wait and see how quickly clinical trials move forward, and how efficacious these agents are on a mass scale.

Best Dental with Dr. Jasmine Naderi

Excerpt from:
Dental Stem Cell Therapy with Dr. Jasmine Naderi, DDS

Fact Checked

This Dr. Axe content is medically reviewed or fact checked to ensure factually accurate information.

With strict editorial sourcing guidelines, we only link to academic research institutions, reputable media sites and, when research is available, medically peer-reviewed studies. Note that the numbers in parentheses (1, 2, etc.) are clickable links to these studies.

The information in our articles is NOT intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice.

This article is based on scientific evidence, written by experts and fact checked by our trained editorial staff. Note that the numbers in parentheses (1, 2, etc.) are clickable links to medically peer-reviewed studies.

Our team includes licensed nutritionists and dietitians, certified health education specialists, as well as certified strength and conditioning specialists, personal trainers and corrective exercise specialists. Our team aims to be not only thorough with its research, but also objective and unbiased.

The information in our articles is NOT intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice.

By Annie Price, CHHC

June 26, 2017

Did you know theres a new typeofdentalfilling that actually triggers your teeth to repair and regenerate themselves? Its true. Researchers from Harvard University and the University of Nottingham recently developed a procedureknown asstem cell fillings. In essence, its aregenerative dental filling that prompts the stem cells inside a personsown tooth to heal itself. This is a revolutionary dental health discovery thatcould make the dreaded root canal a dental procedureof the past.

Its a very common belief that existing tooth decay andcavities cannot be reversed, but thats never actually been true. The practice of drilling a tooth and fillingit with a synthetic material is not the only or thebest way to address cavities. Similarly, a root canal is not necessarily a must; there are natural ways to avoid this intense dental procedure.

One of the newest and best ways might just be stem cell fillings. This new approach couldimpact the lives of millions of dental patients and heal teeth when they are injured from dental disease or dental surgery, two very common health concerns.

Adam Celiz, PhD, research fellow at the University of Nottingham, explains:

Existing dental fillings are toxic to cells and are therefore incompatible with pulp tissue inside the tooth.We have designed synthetic biomaterials that can be used similarly to dental fillings but can be placed in direct contact with pulp tissue to stimulate the native stem cell population for repair and regeneration of pulp tissue and the surrounding dentin. (1)

In short, the biomaterial filling would allow the tooth to heal itself.

Typically, the pulp of the tooth and the nerve are removed during a root canal. I know, it doesnt sound too enjoyable. And unfortunately, it can often be quite painful.The good news is that if stem cell fillings become the norm, then fillings made of synthetic biomaterials would be inserted that stimulate dental stem cells to repair and regenerate dentin. Dentin is the bony tissue that forms the majorityof the tooth under the enamel.

The researchers believe that if stem cell fillings are used in a damaged tooth, then the tooths own stem cells willrepair the disease and damage that typically requires a root canal by todays common dental standards. This could also help dental patients avoid other dangerous chemicals typically found in composite dental fillings and sealants. BPAand related estrogenicchemicals often used in fillings can break down in the mouth, exposing patients to hormone-disrupting chemicals and even the carcinogen formaldehyde. (2)

By reversingcavities naturally, youre not only avoiding fillings, you can also avoid root canals.The common reasons that you might need a root canal include having a deep cavity, having acracked tooth, repeated dental treatment to the tooth or trauma. Want to avoidthe need for a painful root canal? Then you must eliminate tooth decay through good nutrition and proper oral hygiene.

While it may take some time for the stem cell fillings technology to hit your dentists office, there are things you can do now toavoid root canals and cavities.

Stem cells are defined as cells that have the ability to divide and develop into many different cell types in the body during early life and growth. Stem cells canalso help repair the body, or in this case a dental disease or injury, by dividing to replenish cells that are damaged by disease, injury, or normal wear. (4)

The research is looking very promising for the use of tooth stem cells in dental patients. So promising in fact that itearned second place in the materials category at the Royal Society of Chemistrys Emerging Technologies Competition 2016.

Hopefully, this type of treatment might be an optionto the public in the very near future. Imaginebeing able to regenerate components of your own teeth. Were potentially looking at a much brighter future of dentistry where damaged teeth could actually heal themselves, lower filling failure rates andthe need for mostroot canals could even be eliminated all together.

Read Next: Home Remedies for Toothaches

Read this article:
Stem Cell Fillings: A Revolutionary Dental Discovery - Dr. Axe

Dennis M. Lox, M.D. Knee Stem Cell Treatments have been seen Across The Nation.

Dennis M Lox, M.D. is an expert in Knee Stem Cell Injections for those who seek an alternative to the unnecessary complex knee surgery of that in the past by providing Knee Stem Cell Treatment. Dennis M. Lox, M.D. has privately owned Medical Centers that do not partake in the fast chain franchise that other Stem Cell Centers are stuck doing, thus he is able provide a more personalized treatment for your particular injury.

Dennis M. Lox, M.D. centers have a professional, caring environment for patients looking for comfort in their time of need and provids follow-ups on your wellbeing to enhance your recovery. Dennis M. Lox, M.D. has been helping patients since 1990 nationally and internationally and has been the focus of the Stem Cell News Worldwide with his expertise and he continually researches new technologies to further Stem Cell advancements.

PUBLICATIONS:

Lox, D.M., Heine, M.W., and Lox, C.D., Hemostatic Alterations Resulting from Chronic Ethanol Ingestion during Tetracycline Therapy in the Rat, Neurobeh, Toxiocol: Vol. 7, 1985.

Lox, C.D. and Lox, D.M., Effects of Acute Ethanol Intoxication Combined with Secobarbitol Abuse on Homeostasis, General Pharm Vol. 16, 1985. 252-258.

PRESENTATIONS:

Lox, D.M., Sports Medicine and Stem Cells: A Clinical Transformation Presentation at the Select Biosciences Conference: Tissue Engineering and Bio printing, Boston, Massachusetts, February 2015

Lox, D.M., Clinical Regulation of Cytokine and Inflammatory Pathways with Autologous Stem Cell Therapy Presentation at the 17th Clinical Applications for Age Management Medicine Group, The Bellagio Hotel, Las Vegas, Nevada, October 2014

Lox, D.M., Moderator 3rd Annual International Conference on Tissue Science and Regeneration, Valencia, Spain, September 2014

Lox, D.M., Athletes and Avascular Necrosis Presentation at the 3rd Annual International Conference on Tissue Science and Regeneration, Valencia, Spain, September 2014Lox, D.M., Managing Sports and Arthritic Complaints with Stem Cells, Presentation at the Select Biosciences Clinical Translation of Stem Cells, Palm Desert, California, April 2014

Lox, D.M., A Professional Football Player with Failed Knee Surgery: A Case of Treatment with Adipose Derived Stem Cells, Presentation at the Tissue Engineering and Regenerative Medicine International Society Asia Chapter (Termis AP) Annual Conference, Shanghai, China, Oct. 2013

Lox, D.M., Chronic Foot Pain in a Ballerina: Treatment with Regenerative Medicine Presentation at the Tissue Engineering and Regenerative Medicine International Society Asia Pacific Chapter (Termis AP) Annual Conference, Shanghai, China, October 2013

Lox, D.M., Knee Osteoarthritis: Quality of Life (Q o L) Measures Following Autologous Stem Cell Therapy Presentation at the International Cartilage Repair Society Annual Meeting, Izmir, Turkey, September 2013

Lox, D.M., Cytokine Modulation with Nutraceuticals as a Synergistic Mechanism for Regenerative Grafting in Osteoarthritis Repair Presentation at the Tissue Engineering and Regenerative Medicine International Society Meeting, Istanbul, Turkey, June 2013

Lox, D.M., Arthritis: Quality of Life (Q o L) Measures following Mesenchymal Stem Cell Therapy Presentation at the Tissue Engineering and Regenerative Medicine International Society Meeting, Istanbul, Turkey, June 2013

Lox, D.M., Can Healthcare Outcomes Be Quantified with Stem Cell Therapy in Osteoarthritis?

Presentation at the World Stem Cell Summit, West Palm Beach, Fl. December 2012

Lox, D.M., Regenerative Rehabilitation of an Elite Soccer Player, Presentation at the First Annual Symposium on Regenerative Rehabilitation, Pittsburgh, PA, November 3-4, 2011.

Lox, D.M., Regenerative Medicine and Tissue Engineering: Ethical Concerns with Health Care Reform, Presentation at the 2011 World Stem Cell Summit, Pasadena, CA on October 2011.

Lox, D.M., Autologous Adipose-Derived Stem Cells in the Rehabilitation of a Soccer Player, Presentation at the Stem Cells Europe 2011 Conference, Edinburgh, Scotland on July 2011.

Lox, D.M., Autologous Human Adipose-Derived Mesenchymal Stem Cells in Orthopedic Medicine: A Veterinary Correlate, Presentation at the 2nd North American Veterinary Regenerative Medicine Conference, Lexington, Kentucky on June 2011.

Lox, D.M., Regenerative Medicine Techniques in Musculoskeletal Medicine, Presented at the

11th Annual Conference of the International Neural Transplantation and Repair, Sand Key, FL on May 2011.

Lox, D.M., Current Regenerative Medicine Techniques, Tampa, Florida on July 10, 2010.

Lox, D.M., Complex Regional Pain Syndrome Course Presentation, American Academy of Physical Medicine and Rehabilitation Annual Assembly (Moderator: Dennis M. Lox, M.D. Speakers: Jose Ochoa, M.D., Gabor Racz, M.D., Dennis M. Lox, M.D.); Seattle, Washington on November 5, 1998.

Lox, D.M., New Treatments in Myofascial Pain and Fibromyalgia, Presented at the Morton Plant/Mease Health Education Center Countryside, Florida on December 13, 2001.

Lox, D.M., Acute Spinal and Pain Syndromes Presented to the Pinellas County Primary Care and OB/GYN physicians, sponsored by Knoll Pharmaceuticals, 1998.

Lox, D.M., Complex Musculoskeletal Assessment and Treatment, Presented to the Zenith Insurance Company; Sarasota, Florida on September 28, 1998.

Lox, D.M., Fibromyalgia, Presented to Cigna Health Care Physicians, sponsored by Health South Rehabilitation Corporation; Tampa, Florida on September 19, 1998.

Lox, D.M., Evaluation of the Difficult Pain Patient, Presented to the Pinellas County Orthopedic Journal Club, sponsored by Knoll Pharmaceuticals; Clearwater, Florida on September 8, 1998.

Lox, D.M., Fibromyalgia, Presented to the Travelers Insurance Company, sponsored by Health South Rehabilitation Corporation; Tampa, Florida on August 19, 1998.

Lox, D.M., Complex Pain Management, Presented to the Physicians of Collier County, sponsored by Knoll Pharmaceuticals; Naples, Florida on May 16, 1998.

Lox, D.M., Managing Pain in a Managed Care, Presented to the Pinellas County Podiatric Medical Association Meeting; Clearwater, Florida on April 14, 1998.

Lox, D.M., Complex Regional Pain Syndrome: The Historical Perspective from Bonica and Beyond, Presented at the 7th Annual John J. Bonica Vail Winter Pain Conference, sponsored by the Ohio State University Medical Center, College of Medicine, Department of Anesthesiology; Vail, Colorado on March 1998.

Lox, D.M., Pain Management, Presented to Lee County Physicians, sponsored by Knoll Pharmaceuticals; Ft. Myers, Florida in December 1998.

Lox, D.M., Managing Pain in a Managed Care Environment, Presented to the Pinellas County Physicians, sponsored by Knoll pharmaceuticals; Clearwater, Florida in December 1997.

Lox, D.M., Regional Pain Syndrome Update, Presented at the 74th Annual Meeting of the American Congress of Rehabilitation Medicine Pain ISIG; Boston, Massachusetts in September 1997.

Lox, D.M., Physical Medicine for Women Who Hurt all Over (Physical and Somatization Considerations, and Complex Regional Pain Syndrome Update, Presented at the 9th Annual OB/GYN Summer Symposium, Womens Health Care in the 90s, sponsored by the University of Oklahoma Health Sciences Center College of Medicine, Department of Obstetrics and Gynecology; Jackson Hole, Wyoming in August 1997.

Lox, D.M., Replacing the Terms of Reflex Sympathetic Dystrophy and Sympathetically Maintained Pain-An Uphill Battle, Presented at the 13th Annual Update in Physical Medicine and Rehabilitation, sponsored by the University of Utah School of Medicine, Division of Physical Medicine and Rehabilitation, Park City, Utah, March 1997.

Lox, D.M., Complex Regional Pain Syndrome, Presented to Claim Management, Utilization Management, Case Managers, Adjustors and Supervisors of the Travelers/Aetna Insurance Companies; Orlando, Florida in August 1996.

Lox, D.M., Soft Tissue Injuries/RSD/Fibromyalgia-The Rational or Irrational Approach to Diagnosis and Treatment, Presented to Claim Management, Utilization Management, Case Managers and Supervisors of Travelers Insurance Company; Tampa, Florida, 1996.

Lox, D.M., Overview of the Soft Tissue Injury/RSD/Fibromyalgia-The Rational or Irrational Approach to Diagnosis and Treatment, Presented to the Regional Adjustors and Personnel of Geico Insurance Company; Macon, Georgia in May 1996.

Lox, D.M., Causalgia/RSD/SMP-History and Treatment, Presented during the Re-Employment rules of Florida Workers= Compensation Conference, sponsored by the Southwest Chapter of NARPPS in May 1996 (2 CME credits).

Lox, D.M., RSD-Treatment Options for the 90s, Presented to the Florida Association of Rehabilitation Professionals in the Private Sector (FARPPS) in March 1996 (2 CME credits).

Lox, D.M., Causalgia/RSD/SMP-The 100 Year War, Presented to The Florida Association of Rehabilitation Professionals in the Private Sector in January 1996 (2 CME credits)

Lox, D.M., The Differential Diagnosis of Spinal Injuries, Presented to the Intracorp Rehabilitation Nurses in April 1992 (4 CME credits).

Lox, D.M., A Physiatrist Approach to Industrial Industries, Presented to the Florida Rehabilitation Nurses in May 1991 (4 CME credits).

Lox, D.M., Skiing Injuries: Prevention and Rehabilitation, Presented at the North American Medical and Dental Association Seminar; Vail, Colorado in February 1989.

Lox, D.M., The Failed Back Patient, Presented at the Annual Texas Physical Medicine and Rehabilitation Society Meeting; Austin, Texas in August 1989.

Lox, D.M., Dermatomal Somatosensory Evoked Potentials and Gadolinium-MRI in the Evaluation of Chronic Low Back Pain, Presented at the 50th Annual Session of the American Academy of Physical Medicine and Rehabilitation; San Antonio, Texas in November 1989.

Lox, D.M., The Evaluation and Treatment of Lumbar Spine Disorders, Presented at the University of Texas Health Science Center at San Antonio, Department of Allied Health; San Antonio, Texas in December 1988.

Originally posted here:
Our Doctors - Knee Stem Cells